Re:The Looming Decline of the Public Research University
by thanatropism on Wednesday October 18, 2017 @09:26PM
(#15504740)
> What we've done is essentially say that "research isn't valuable unless the researcher gets federal funds to do so, or is paid for by a private corporation."
This has happened in federal republics: in the past states were more powerful and expected to bear a larger portion of the Public Good-producing apparatus. Then some stuff happens (maybe production is de-localized even if it remains intra-national; maybe states enter races-to-the-bottom in state taxes to attract industries, etc.) and only the federal government is able to deal with problems.
So that's probably orthogonal to research.
The basic problem: research broadly framed is a public good, like a lighthouse. But hey, math research is thoroughly public, theorems are all utterly equivalent to a small number of rules of metamathematics. OTOH drug research can often be access-controlled so it can be made profitable. This is the pure-applied spectrum, and all the innovative solutions are about having private actors pay for stuff at the margins in the applied end. For example: I work with symplectic numerical integrators, maybe Mathworks out of its enlightened self-interest should pay me so that even if the research comes out in papers it will be first on its MATLAB suite of engineering stuff. See?
This has happened in federal republics: in the past states were more powerful and expected to bear a larger portion of the Public Good-producing apparatus. Then some stuff happens (maybe production is de-localized even if it remains intra-national; maybe states enter races-to-the-bottom in state taxes to attract industries, etc.) and only the federal government is able to deal with problems.
So that's probably orthogonal to research.
The basic problem: research broadly framed is a public good, like a lighthouse. But hey, math research is thoroughly public, theorems are all utterly equivalent to a small number of rules of metamathematics. OTOH drug research can often be access-controlled so it can be made profitable. This is the pure-applied spectrum, and all the innovative solutions are about having private actors pay for stuff at the margins in the applied end. For example: I work with symplectic numerical integrators, maybe Mathworks out of its enlightened self-interest should pay me so that even if the research comes out in papers it will be first on its MATLAB suite of engineering stuff. See?